Skip to main content
. 2022 Apr 4;12:852952. doi: 10.3389/fonc.2022.852952

Figure 5.

Figure 5

miR-124a overexpression inhibits established metastases. (A) The 113/6-4L melanoma cells were transduced with GFP-Luciferase followed by TRIPZ-Scr or TRIPZ-miR-124a lentiviral infections. Efficient miRNA-124 overexpression after doxycycline treatment in vitro was assessed by RT-qPCR (unpaired t test; *****p = 0.000005). (B) Schematic representation of in vivo metastasis assay with inducible overexpression of miR-124a: The 113/6-4L-GFP-Luciferase cells transduced with doxycycline-inducible control (TRIPZ-miR-Scr) or (TRIPZ-miR-124a) tagged with a tRFP reporter were selected with puromycin, and ultrasound-guided intracardiac injection was performed in NSG mice (n = 11 per group). Mice were initiated on doxycycline (200 mg/kg) chow 8 days post-injection. (C) RFP and GFP fluorescence images of brain, lung, liver, and kidneys in all mice are shown, and the areas of metastatic lesions were plotted using ImageJ (red dots: RFP+ metastases; green dots: GFP+ metastases). Unpaired t test was used for statistical significance of differences in brain (***p = 0.0006 for RFP+ metastases in miR124a vs. miR-Scr group; ns, p = 0.274 for GFP+ in miR124a vs. miR-Scr group), lung (**p = 0.0041 for RFP+ metastases in miR124a vs. miR-Scr group; ***p = 0.00056 for GFP+ in miR124a vs. miR-Scr group), liver (*****p < 0.000001 for RFP+ metastases in miR124a vs. miR-Scr group; ns, p = 0.056 for GFP+ in miR124a vs. miR-Scr group), and kidney (***p = 0.00033 for RFP+ metastases in miR124a vs. miR-Scr group; ns, p = 0.058 for GFP+ in miR124a vs. miR-Scr group) metastases. (D) Expression of miR-124a in RFP-/GFP+ and RFP+/GFP+ liver metastatic foci dissected from two representative mice (#16 and #18) from the miR124a group is measured by quantitative RT-qPCR (unpaired t test; *p = 0.018 for mouse 16 and ***p = 0.0011 and **p = 0.005 for mouse 18). (E) Representative images of the liver and kidney sizes of two mice from both groups are shown. ns, non significant.